Results 91 to 100 of about 63,264 (143)

Isorhamnetin ameliorates ovariectomy-induced osteoporosis in female rats by regulating the receptor activator of nuclear factor kappa B ligand, osteoprotegerin, bone morphogenetic protein 2 and runt-related transcription factor 2 signaling pathway. [PDF]

J Vet Med Sci
Jiao H, Zheng K.
europepmc   +1 more source

Circulating receptor activator of nuclear factor kappa-B ligand (RANKL) levels predict response to immune checkpoint inhibitors in advanced non-small cell lung cancer (NSCLC). [PDF]

J Immunother Cancer
Iuliani M, Simonetti S, Cristofani L, Cavaliere S, Cortellini A, Russano M, Vincenzi B, Tonini G, Santini D, Pantano F.   +9 more
europepmc   +1 more source

Effect of denosumab, a human monoclonal antibody of receptor activator of nuclear factor kappa-B ligand (RANKL), upon glycemic and metabolic parameters: Effect of denosumab on glycemic parameters. [PDF]

Medicine (Baltimore), 2019
Abe I, Ochi K, Takashi Y, Yamao Y, Ohishi H, Fujii H, Minezaki M, Sugimoto K, Kudo T, Abe M, Ohnishi Y, Mukoubara S, Kobayashi K.   +12 more
europepmc   +1 more source

LMS-based continuous pediatric reference values for soluble receptor activator of nuclear factor kappa B ligand (sRANKL) and osteoprotegerin (OPG) in the HARP cohort. [PDF]

Osteoporos Int
Tietze H, Pott V, Kanzelmeyer N, Memaran N, Baumann U, Mindermann C, Suhlrie A, Drube J, Melk A, Das AM, Schnabel D, Haffner D, Leifheit-Nestler M.   +12 more
europepmc   +1 more source

Receptor Activator of Nuclear Factor Kappa B (RANK) and Clinicopathological Variables in Endometrial Cancer: A Study at Protein and Gene Level. [PDF]

Int J Mol Sci, 2018
Gómez R, Castro A, Martínez J, Rodríguez-García V, Burgués O, Tarín JJ, Cano A.   +6 more
europepmc   +1 more source

The Effects of microRNA-515-5p on the Toll-Like Receptor 4 (TLR4)/JNK Signaling Pathway and WNT1-Inducible-Signaling Pathway Protein 1 (WISP-1) Expression in Rheumatoid Arthritis Fibroblast-Like Synovial (RAFLS) Cells Following Treatment with Receptor Activator of Nuclear Factor-kappa-B Ligand (RANKL). [PDF]

Med Sci Monit, 2020
Cai D, Hong S, Yang J, San P.
europepmc   +1 more source

Artemisia annua extract prevents ovariectomy-induced bone loss by blocking receptor activator of nuclear factor kappa-B ligand-induced differentiation of osteoclasts. [PDF]

Sci Rep, 2017
Lee SK, Kim H, Park J, Kim HJ, Kim KR, Son SH, Park KK, Chung WY.   +7 more
europepmc   +1 more source

Receptor activator of nuclear factor kappa-B ligand (RANKL) but not sclerostin or gene polymorphisms is related to joint destruction in early rheumatoid arthritis. [PDF]

Clin Rheumatol, 2017
Boman A, Kokkonen H, Ärlestig L, Berglin E, Rantapää-Dahlqvist S.   +4 more
europepmc   +1 more source

Effect of Lead Nanoparticles Inhalation on Bone Calcium Sensing Receptor, Hydroxyapatite Crystal and Receptor Activator of Nuclear Factor-Kappa B in Rats. [PDF]

Acta Inform Med, 2016
Leonas R, Noor Z, Rasyid HN, Madjid TH, Tanjung FA.   +4 more
europepmc   +1 more source

Receptor activator of nuclear factor kappa B (RANK) expression in primary breast cancer correlates with recurrence-free survival and development of bone metastases in I-SPY1 (CALGB 150007/150012; ACRIN 6657). [PDF]

Breast Cancer Res Treat, 2017
Vidula N, Yau C, Li J, Esserman LJ, Rugo HS.   +4 more
europepmc   +1 more source